RT @brummendorf@twitter.com

Great #ASH2022 presentation of the interim analysis of the first 95 ET patients treated within the #RuxoBEAT trial showing superiority in symptom score improvement in the #ruxolitinib arm by ⁦@KoschmiederS@twitter.com⁩ from ⁦@UniklinikAachen@twitter.com⁩ ⁦@RWTH@twitter.com⁩ ⁦@GsgMpn@twitter.com⁩ #CRU344

🐦🔗: https://twitter.com/brummendorf/status/1602357032857862144

RT @rschneiderlab@twitter.com

@rkramann@twitter.com @rkramann@twitter.com shares commonalities in #fibrosis across organs - always much food for thought and new ideas on collaborative projects. So happy to have fantastic collaboration partners in such close proximity @GleitzHelene@twitter.com @JessPritchard25@twitter.com @vanvanka123@twitter.com #MPNsm #CRU344 @dfg_public@twitter.com.

🐦🔗: https://twitter.com/rschneiderlab/status/1591000725068341249